Tools
ToolsALFAROUK, Khalid Omer, ALHOUFIE, Sari TS, HIFNY, Abdelhameed, SCHWARTZ, Laurent, ALQAHTANI, Ali S, AHMED, Samrein, ALQAHTANI, Ali M, ALQAHTANI, Saad S, MUDDATHIR, Abdel Khalig, ALI, Heyam, BASHIR, Adil HH, IBRAHIM, Muntaser E, GRECO, Maria Raffaella, CARDONE, Rosa A, HARGUINDEY, Salvador and RESHKIN, Stephan Joel (2021). Of mitochondrion and COVID-19. Journal of enzyme inhibition and medicinal chemistry, 36 (1), 1258-1267. [Article]
Documents
33569:641138
Preview
PDF
Ahmed-OfMitochondrionAndCOVID-19(VoR).pdf - Published Version
Available under License Creative Commons Attribution.
Ahmed-OfMitochondrionAndCOVID-19(VoR).pdf - Published Version
Available under License Creative Commons Attribution.
Download (1MB) | Preview
Abstract
COVID-19, a pandemic disease caused by a viral infection, is associated with a high mortality rate. Most of the signs and symptoms, e.g. cytokine storm, electrolytes imbalances, thromboembolism, etc., are related to mitochondrial dysfunction. Therefore, targeting mitochondrion will represent a more rational treatment of COVID-19. The current work outlines how COVID-19's signs and symptoms are related to the mitochondrion. Proper understanding of the underlying causes might enhance the opportunity to treat COVID-19.
More Information
https://orcid.org/0000-0001-8656-6117Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
 |
View Item |